# TOOMER THERAPEUTICS, INC.: Development of ARIH1 inhibitors as a novel targeted therapy in cancer

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | TOOMER THERAPEUTICS, INC. |
| Location | MOUNT PLEASANT, SC |
| Project | Development of ARIH1 inhibitors as a novel targeted therapy in cancer |
| Project number | 1R41CA302048-01A1 |
| Mechanism | R41 |
| Institute | National Cancer Institute |
| Award | $400,000 |
| Awarded | 2026-09-02 |
| Project period | 2026-09-02 to 2027-08-31 |
| UEI | Q53BUHFU7936 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11312958). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.